Aesica has entered a partnership with the Centre for Pharmaceutical Engineering Science at the University of Bradford, enabling the Bradford team to use Aesica’s GMP capabilities and assets, and giving Aesica access to the Centre’s research facilities. The Centre offers several processing technologies, including hot melt extrusion, and will rely on the GMP expertise of the formulation development team at Aesica to manufacture GMP clinical trial supplies.

Paul Titley, managing director of formulation development at Aesica, said, “We provide GMP contract manufacturing services to six other universities, but this partnership is particularly important and unique as it is mutually beneficial. While the team at Bradford has development expertise in several key approaches and as such can evaluate the viability of compounds presented by virtual and small pharma organizations, our GMP expertise is crucial to take the compounds into clinical trials. In addition, the facilities at the Centre for Pharmaceutical Engineering Science will enable us to further enhance our overall formulation development service offering which will add value to our existing clients.”

Dr. Riddhi Shukla, business development manager at the Centre for Pharmaceutical Engineering Science, said, “Aesica is a well established pharmaceutical company with exemplary GMP credentials, which we were keen to tap into for the benefit of our contacts within the multinational pharma community. Our facilities at the Centre are second to none and we believe this coupled with our research expertise will deliver significant benefits to Aesica as the partnership evolves.”